| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $330.5M | +204.7% |
| R&D Expense | $423.9M | +18.2% |
| SG&A Expense | $103.4M | +14.2% |
| Operating Income | -$196.7M | +42.3% |
| Income Tax | $30K | +42.9% |
| Net Income | -$145.2M | +55.5% |
| EPS (Basic) | -$1.06 | +59.2% |
| EPS (Diluted) | -$1.06 | +59.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $127.1M | -41.7% |
| Short-term Investments | $907.4M | -18.8% |
| Accounts Receivable | $3.4M | -63.2% |
| Current Assets | $1.06B | -22.5% |
| Total Assets | $1.15B | -21.0% |
| Current Liabilities | $78.0M | -78.6% |
| Total Liabilities | $123.0M | -70.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$358.0M | -46.3% |
| Capital Expenditures | $12.9M | -27.4% |
| Investing Cash Flow | $249.3M | +276.3% |
| Financing Cash Flow | $17.8M | -94.3% |
| Free Cash Flow | -$370.9M | -41.3% |
| Stockholders' Equity |
| $1.03B |
| -1.1% |